KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,258,481 | -29.3% | 703,062 | +34.2% | 0.01% | -50.0% |
| Q4 2022 | $1,780,879 | +62.5% | 523,788 | +115.6% | 0.01% | +25.0% |
| Q2 2022 | $1,096,000 | -28.9% | 242,997 | +65.9% | 0.01% | -66.7% |
| Q1 2021 | $1,541,000 | +9.0% | 146,442 | +60.3% | 0.02% | +20.0% |
| Q4 2020 | $1,414,000 | +198.9% | 91,338 | +181.6% | 0.02% | +185.7% |
| Q3 2020 | $473,000 | – | 32,431 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |